Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
42 hedge funds and large institutions have $13.1M invested in Singular Genomics Systems, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 7 closing their positions.
8% more capital invested
Capital invested by funds: $12.1M → $13.1M (+$968K)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.37% less ownership
Funds ownership: 35.7% → 34.34% (-1.4%)
11% less funds holding
Funds holding: 47 → 42 (-5)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QM
QVIDTVM Management
The Woodlands,
Texas
|
+$95.1K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$55.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$36K |
| 4 |
Millennium Management
New York
|
+$29.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$481K |
| 2 |
BlackRock
New York
|
-$48.3K |
| 3 |
WC
Weil Company
San Diego,
California
|
-$35.6K |
| 4 |
Renaissance Technologies
New York
|
-$20.5K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$16.1K |
OMIC Hedge Fund Activity: Q1 2024 in Review
42 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q1 2024, worth a combined $13.1M — up 8% from $12.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of OMIC and 2 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 7 added.
The largest buyer was QVIDTVM Management, adding an estimated $95.1K. The largest seller was Bank of Montreal, exiting entirely with an estimated $481K sold.
- 42 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q1 2024, down from 47 in Q4 2023.
- Funds reported $13.1M of Singular Genomics Systems, Inc. Common Stock stock for Q1 2024, up 8% quarter-over-quarter.
- 2 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q1 2024 and 7 closed out, a net change of -5 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q1 2024 was QVIDTVM Management, an estimated $95.1K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q1 2024 was Bank of Montreal, an estimated $481K sold.
Based on aggregated 13F filings for Q1 2024.